Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2012
09/07/2012WO2012039642A8 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
09/07/2012WO2012034871A3 Method for producing active ingredient beads
09/07/2012WO2012026908A3 Cefpodoxime proxetil formulations comprising taste regulating agent
09/07/2012WO2012017402A3 Zeolites having a neuro-protective effect
09/07/2012WO2012016646A9 Quetiapine tablets
09/07/2012WO2012011740A9 Method for preparing microspheres and microspheres produced thereby
09/07/2012WO2012010883A3 Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile
09/07/2012WO2012010465A3 Optimised hydrogel matrix systems containing non-ionic emulsifiers
09/07/2012WO2011157720A3 Ivabradine-containing pharmaceutical composition with modified release
09/07/2012WO2011101734A3 Taste-masked powder for suspension compositions of methylprednisolone
09/07/2012WO2011089234A8 Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
09/07/2012WO2008138490A3 Odour selection
09/07/2012CA2829044A1 Silicone-based ophthalmic formulations
09/07/2012CA2829040A1 Non-aqueous silicone-based ophthalmic formulations
09/07/2012CA2828971A1 Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it
09/07/2012CA2828883A1 Homeopathic therapeutic method and compositions
09/07/2012CA2828754A1 Coated solid pharmaceutical preparation
09/07/2012CA2828685A1 Stable compositions of tetrahydrobiopterin
09/07/2012CA2828316A1 Prucalopride oral solution
09/07/2012CA2828050A1 Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols
09/07/2012CA2827892A1 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
09/07/2012CA2827242A1 Chewable vehicle for mouth absorption
09/07/2012CA2825485A1 Use of a viscoelastic fluid for producing a medicinal product for surgically treating the eye
09/07/2012CA2824095A1 Vaccination in elderly patients
09/07/2012CA2824094A1 Vaccination in newborns and infants
09/07/2012CA2822021A1 Vesicle compositions
09/06/2012US20120226245 Transdermally absorbable preparation
09/06/2012US20120226224 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
09/06/2012US20120226090 Protection Against and Treatment of Ionizing Radiation
09/06/2012US20120225953 Self-Emulsifying Active Ingredient Formulation and the Use of this Formulation
09/06/2012US20120225145 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus
09/06/2012US20120225129 Conjugates, particles, compositions, and related methods
09/06/2012US20120225128 Method for carrying therapeutic substances into cells
09/06/2012US20120225127 Clay nanocomposite forming microcapsule useful for guest encapsulation and process thereof
09/06/2012US20120225125 Nanoparticles for Extravascular Administration
09/06/2012US20120225124 Stable laquinimod preparations
09/06/2012US20120225123 Use of Synergistic Combinations of an Avermectin and an Antineoplastic Compounds for the Treatment of Hematological Malignancies
09/06/2012US20120225122 Abuse-Resistant Formulations
09/06/2012US20120225121 Bioequivalent formulation of efavirenz
09/06/2012US20120225120 Stable pharmaceutical composition and methods of using same
09/06/2012US20120225119 Therapeutic combination for painful medical conditions
09/06/2012US20120225118 Compositions for delivery of insoluble agents
09/06/2012US20120225117 Process for production of w/o/w emulsion, process for production of liposome employing the process, and porous membrane for use in the processes
09/06/2012US20120225116 Biodegradable polyphosphazenes containing pyrrolidone side groups
09/06/2012US20120225115 Methods and Compositions for Improved Deliver, Expression or Activity of RNA Interference Agents
09/06/2012US20120225114 Modifying Macrophage Phenotype for Treatment of Disease
09/06/2012US20120225113 Method for treating tuberculosis
09/06/2012US20120225112 Method and Apparatus for Alcohol Administration
09/06/2012US20120225110 Patch and patch preparation
09/06/2012US20120225108 Products for improving wound healing
09/06/2012US20120225107 Stable skin and scar treatment composition
09/06/2012US20120225105 Sugar-based dispersion
09/06/2012US20120225103 Transdermal Therapeutic System Containing a Pramipexol Active Agent
09/06/2012US20120225102 Perfluorocarbon gel formulations
09/06/2012US20120225101 Multifunctional in situ polymerized network via thiol-ene and thiol-maleimide chemistry
09/06/2012US20120225100 Articlea and processes for Making a Porous Disintegratable Solid Substrate for Personal Health Care Applications
09/06/2012US20120225099 Compositions for and methods of activating guanylyl cyclase c
09/06/2012US20120225098 Biofilm inhibiting composition
09/06/2012US20120225021 Stable colloidal gold nanoparticles with controllable surface modification and functionalization
09/06/2012US20120225018 Homeopathic therapeutic method and compositions
09/06/2012US20120225017 Mixed micelles
09/06/2012US20120225011 Glassy compositions
09/05/2012EP2495248A1 Bridged artificial nucleoside and nucleotide
09/05/2012EP2494995A2 Patch and patch preparation
09/05/2012EP2494993A2 Amino acid lipids and uses thereof
09/05/2012EP2494973A1 Topical compositions for the treatment and prevention of skin diseases, in particular radiation dermatitis caused by ionising radiation
09/05/2012EP2494969A1 Pharmaceutical formulations of HDAC inhibitors
09/05/2012EP2494968A1 Compound, in particular dermatological ointment with Olea Europaea Fruit Oil and Silver
09/05/2012EP2494966A1 Stable composition of rasagiline
09/05/2012EP2494964A1 Combinations of valsartan and amlodipine
09/05/2012EP2494963A1 Combinations of valsartan and amlodipine
09/05/2012EP2494962A2 Pulmonary delivery for levodopa
09/05/2012EP2494961A1 Drug formulations having reduced abuse potential
09/05/2012EP2494960A1 Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
09/05/2012EP2494959A1 Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
09/05/2012EP2494958A1 Amphiphilic Entity Nanoparticles
09/05/2012EP2494957A1 Submicro emulsion of paclitaxel using steroid complex as intermediate carrier
09/05/2012EP2494956A1 Paclitaxel/steroidal complex
09/05/2012EP2494955A2 Stable liquid pharmaceutical composition based on trazodone
09/05/2012EP2494954A2 Ophthalmic composition based on lactobionic acid useful for reducing corneal edema and inflammation
09/05/2012EP2494953A1 Cosmetic and external skin preparation, and medical instrument
09/05/2012EP2493915A1 Stabilization of bio-sensors for in vivo applications
09/05/2012EP2493572A1 Angiogenesis promoted by caged growth factors
09/05/2012EP2493514A1 Sterilization of biodegradable hydrogels
09/05/2012EP2493509A2 Aqueous composition for topical application, method of preparation, uses and device
09/05/2012EP2493508A2 Transdermal pharmaceutical compositions comprising active agents
09/05/2012EP2493484A2 Gastroretentive oral high dose zinc preparations
09/05/2012EP2493483A2 Rosacea topical skin treatment method and formulation
09/05/2012EP2493477A2 Bazedoxifene formulations with antioxidants
09/05/2012EP2493474A2 Methods and compositions for sustained delivery of drugs
09/05/2012EP2493464A1 Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms
09/05/2012EP2493459A1 Ocular drug delivery devices
09/05/2012EP2493458A2 Multi-functional biodegradable particles for selectable targeting, imaging, and therapeutic delivery and use thereof for treating ocular disorders
09/05/2012EP2493457A1 Fast dissolving solid dosage form
09/05/2012EP2493456A2 Solid dispersion of rifaximin
09/05/2012EP2493455A1 Composition comprising fesoterodine and fiber
09/05/2012EP2493454A2 Fast dissolving/disintegrating coating compositions
09/05/2012EP2493453A1 Use of biocompatible compositions and materials polymerized therefrom for inhibiting angiogenesis
09/05/2012EP2493452A2 Stable protective coatings for pharmaceutical dosage forms
09/05/2012EP2493333A2 Stable thickener formulations
1 ... 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 ... 2991